Inspire Medical Systems, Inc. (NYSE:INSP) Receives $228.82 Consensus Target Price from Brokerages

Inspire Medical Systems, Inc. (NYSE:INSP - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eleven brokerages that are currently covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average twelve-month target price among brokers that have covered the stock in the last year is $228.82.

Several research analysts recently issued reports on the company. Truist Financial cut their price objective on Inspire Medical Systems from $250.00 to $235.00 and set a "buy" rating for the company in a research report on Tuesday, February 11th. Morgan Stanley cut their price target on Inspire Medical Systems from $230.00 to $220.00 and set an "overweight" rating for the company in a report on Tuesday, February 11th. KeyCorp reaffirmed an "overweight" rating and set a $234.00 price objective (down previously from $236.00) on shares of Inspire Medical Systems in a research note on Friday, January 24th. Bank of America raised shares of Inspire Medical Systems from a "neutral" rating to a "buy" rating and boosted their target price for the company from $220.00 to $255.00 in a research note on Wednesday, November 20th. Finally, Piper Sandler reduced their target price on shares of Inspire Medical Systems from $260.00 to $233.00 and set an "overweight" rating on the stock in a report on Monday, February 10th.

Insider Transactions at Inspire Medical Systems

In other Inspire Medical Systems news, insider Randy Ban sold 25,584 shares of the business's stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $183.50, for a total transaction of $4,694,664.00. Following the completion of the sale, the insider now owns 7,259 shares of the company's stock, valued at approximately $1,332,026.50. The trade was a 77.90 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CTO John Rondoni sold 583 shares of the firm's stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $170.49, for a total value of $99,395.67. Following the completion of the transaction, the chief technology officer now owns 10,424 shares in the company, valued at approximately $1,777,187.76. This trade represents a 5.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 26,225 shares of company stock worth $4,806,530 in the last three months. Company insiders own 4.10% of the company's stock.

Remove Ads

Institutional Trading of Inspire Medical Systems

A number of institutional investors have recently modified their holdings of the company. B. Metzler seel. Sohn & Co. Holding AG acquired a new position in Inspire Medical Systems during the third quarter valued at approximately $1,929,000. Thrivent Financial for Lutherans raised its stake in shares of Inspire Medical Systems by 39.7% in the 3rd quarter. Thrivent Financial for Lutherans now owns 110,580 shares of the company's stock valued at $23,337,000 after acquiring an additional 31,444 shares during the period. Merit Financial Group LLC acquired a new position in shares of Inspire Medical Systems during the 4th quarter valued at $313,000. Principal Financial Group Inc. boosted its position in Inspire Medical Systems by 3,812.6% during the 3rd quarter. Principal Financial Group Inc. now owns 141,089 shares of the company's stock worth $29,777,000 after purchasing an additional 137,483 shares during the period. Finally, Public Employees Retirement System of Ohio increased its holdings in Inspire Medical Systems by 9.4% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 36,361 shares of the company's stock valued at $7,674,000 after purchasing an additional 3,125 shares in the last quarter. Hedge funds and other institutional investors own 94.91% of the company's stock.

Inspire Medical Systems Price Performance

INSP traded up $8.24 during trading on Wednesday, reaching $183.34. 550,140 shares of the stock were exchanged, compared to its average volume of 576,532. The company has a market capitalization of $5.44 billion, a price-to-earnings ratio of 105.98, a P/E/G ratio of 2.86 and a beta of 1.48. Inspire Medical Systems has a 1 year low of $123.00 and a 1 year high of $257.40. The business's 50 day moving average price is $187.08 and its two-hundred day moving average price is $192.70.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last released its quarterly earnings data on Monday, February 10th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $0.74 by $0.41. Inspire Medical Systems had a net margin of 6.67% and a return on equity of 8.19%. On average, analysts anticipate that Inspire Medical Systems will post 2.16 EPS for the current year.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.